Unique Case of Myeloproliferative Neoplasm with Two Rare Clonal Abnormalities: Rare <b><i>JAK2</i></b> Exon 12<b><i></i></b> Mutation and Rare e14a3 (b3a3) BCR/ABL Fusion Transcript
Author(s) -
Mahesh Swaminathan,
Keyur P. Patel,
Julie Huynh-Lu,
Guping Tang,
Zhuang Zuo,
Roberto N. Miranda,
Srđan Verstovšek
Publication year - 2018
Publication title -
acta haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 56
eISSN - 1421-9662
pISSN - 0001-5792
DOI - 10.1159/000494427
Subject(s) - myeloproliferative neoplasm , polycythemia vera , exon , philadelphia chromosome , essential thrombocythemia , cancer research , mutation , myeloproliferative disorders , myelofibrosis , myeloid leukemia , medicine , janus kinase 2 , myeloid , bone marrow , biology , chromosomal translocation , genetics , gene
Myeloproliferative neoplasms (MPNs) are clonal disorders divided into Philadelphia (Ph) chromosome-positive chronic myeloid leukemia (CML) or Ph chromosome-negative MPNs. Co-occurrence of these disease entities is very rare and typically involves presence of common p190 or p210 BCR/ABL fusion transcript (responsible for CML) along with JAK2V617F mutation (most common driver mutation in Ph-negative MPNs). Because of the rarity of such cases, it is not clear if the outcomes are any different in these patients. In this article, we report a unique patient with polycythemia vera driven by a rare complex in-frame deletion-insertion mutation in JAK2 exon 12, and CML driven by uncommon p210 e14a3 (b3a3) BCR/ABL fusion transcript. We describe clinical and laboratory features, bone marrow pathology, treatment, and overall outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom